DSS, Inc. (DSS) Dividend History

DSS, Inc. is a technology company specializing in advanced 3D imaging and electronic design automation solutions. It provides products and services primarily for defense, aerospace, and industrial applications, focusing on high-performance visualization, imaging, and electronic component design and testing.

Dividend History

DSS, Inc. currently does not pay dividends

Company News

  • NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform.

    GlobeNewswire Inc.
  • Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company

    GlobeNewswire Inc.
  • Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024. DouYu International shares jumped 14.2% to $0.8320 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Nova LifeStyle, Inc. (NASDAQ: NVFY) shares jumped 204% to $4.71. Cingulate Inc. (NASDAQ: CING) climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD). Bone Biologics Corporation (NASDAQ: BBLG) gained 62.2% to $7.54. SenesTech, Inc. (NASDAQ: SNES) shares climbed 50.7% to $1.30. HC Wainwright & Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4. Microbot Medical Inc. (NASDAQ: MBOT) rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study. Sidus Space, Inc. (NASDAQ: SIDU) gained 32% to $5.81. DatChat, Inc. (NASDAQ: DATS) rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators. SEALSQ Corp (NASDAQ: LAES) gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure cryptocurrency transactions against the looming threat of quantum computing. Ocean Biomedical, Inc. (NASDAQ: OCEA) surged 21.4% to $0.7299. DSS, Inc. (NYSE: DSS) jumped 21% to $0.1477. RenovoRx, Inc. (NASDAQ: RNXT) gained 20% to $1.2599. Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose 20% to $3.6250. The FDA recently approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older. Envoy ...

    Benzinga
  • NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the “Reverse Split Range”), at any time on or before April 20, 2024, with the Board having the discretion as to whether or not the Reverse Split is to be effected, and with the exact ratio to be set at a whole number within the Reverse Split Range as determined by the Chief Executive Officer in his discretion.

    GlobeNewswire Inc.
  • Option for Fourth Year Brings Potential Revenue to Over $15 Million Option for Fourth Year Brings Potential Revenue to Over $15 Million

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 19:49:15 UTC